Anti-tumour necrosis factor therapy associated with cutaneous vasculitis
Open Access
- 1 December 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 41 (12) , 1450-1452
- https://doi.org/10.1093/rheumatology/41.12.1450
Abstract
Sir, We read with interest the letter by McCain et al. [1] and we wish to add our experience of a case of probable vasculitis or cutaneous reaction secondary to anti‐tumour necrosis factor (anti‐TNF) therapy, as has been noted by others. While injection site reactions can occur in up to 20% of patients receiving etanercept [2], more generalized reactions are only recently being recognized [1, 3–6].Keywords
This publication has 0 references indexed in Scilit: